Aging
Navigate
Submit an Article
Research Paper|Volume 11, Issue 6|pp. 1716–1732
Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients
Back to articleFigure 1(1 of 6)
100%
Figure 1
Figure 1.Flow diagram of eligible cases selection in present study.
Figure 1 — Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients | Aging